HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction.
Hisashi AkiyamaCaitlin M MillerChelsea R EttingerAnna C BelkinaJennifer E Snyder-CappioneSuryaram GummuluruPublished in: Nature communications (2018)
Low levels of type I interferon (IFN-I) are thought to be a driving force for immune activation and T-cell exhaustion in HIV-1 infected individuals on combination antiretroviral therapy (cART), though the causative mechanisms for persistent IFN-I signaling have remained unclear. Here, we show Rev-CRM1-dependent nuclear export and peripheral membrane association of intron-containing HIV-1 RNA, independent of primary viral sequence or viral protein expression, is subject to sensing and signaling via MAVS, resulting in IFN-I-dependent pro-inflammatory responses in macrophages. Additionally, HIV-1 intron-containing-RNA-induced innate immune activation of macrophages leads to upregulation of inhibitory receptor expression and functional immune exhaustion of co-cultured T cells. Our findings suggest that persistent expression of HIV-1 intron-containing RNA in macrophages contributes to chronic immune activation and T-cell dysfunction and that use of HIV RNA expression inhibitors as adjunct therapy might abrogate aberrant inflammation and restore immune function in HIV-infected individuals on cART.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv aids
- hiv infected patients
- poor prognosis
- innate immune
- oxidative stress
- dendritic cells
- hiv testing
- immune response
- hepatitis c virus
- stem cells
- nucleic acid
- men who have sex with men
- long non coding rna
- binding protein
- smoking cessation
- south africa
- bone marrow
- mesenchymal stem cells
- replacement therapy